In a significant development for non-invasive aesthetic treatments, Merz Aesthetics has received approval from the U.S. Food and Drug Administration (FDA) for the use of its RADIESSE® dermal filler to treat wrinkles in the décolleté area, commonly referred to as the upper chest region. This marks a major expansion of the product’s approved uses, as RADIESSE® was previously only cleared for facial wrinkle treatment.
FDA expands RADIESSE® approval to décolleté area
The FDA granted approval for the new use of RADIESSE® on April 8, 2026. This decision provides a new option for addressing wrinkles and crepey skin in the décolleté area, an area prone to visible signs of aging and a common concern among aesthetic patients.
The dermal filler, which is calcium-based, works by stimulating the body’s natural collagen production, creating smoother and more youthful-looking skin. Known for its effectiveness in facial wrinkle treatments, RADIESSE® can now be used to target the delicate chest area.
sbb-itb-02f5876
A step forward in aesthetic treatments
The expanded approval represents an important advancement in the field of non-invasive cosmetic procedures. The décolleté area often demands specialized care due to its thin and delicate skin, and the new FDA clearance offers patients an innovative solution to address these challenges.
About RADIESSE® and Merz Aesthetics
RADIESSE® is a dermal filler developed by Merz Aesthetics, a leading global aesthetics company. The product has a long-standing reputation for delivering effective wrinkle treatment by stimulating collagen production. This latest FDA approval underscores the product’s versatility and its potential to address a broader range of aesthetic concerns.
What’s next?
Following this approval, healthcare providers can now offer RADIESSE® as a treatment option for individuals looking to rejuvenate their décolleté area. With its proven results and now-expanded application, RADIESSE® is set to become a key option for those seeking non-invasive solutions for aging skin.
The FDA’s decision highlights the growing demand for advanced, non-surgical treatments, and Merz Aesthetics continues to lead in delivering innovative solutions to meet this need.
The expanded use of RADIESSE® provides a promising new tool for patients looking to restore confidence in their appearance while addressing common signs of aging in the upper chest area.
